MCA MCA-F-501MCA-F-501/14, Version 1 – 24 January 2025
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
MCA-F-501/14, Version 1 – 24 January 2025 is the official MCA identifier for “Line Listing of Adverse Events and Serious Adverse Events”. MCA-F-501/14, Version 1 – 24 January 2025 is the official identifier MCA uses for this instrument.
- Instrument
- MCA-F-501
- Full name
- MCA-F-501/14, Version 1 – 24 January 2025
- Category
- Clinical Trials
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Line Listing of Adverse Events and Serious Adverse Events
Complete one-page adverse-event and serious-adverse-event line-listing form, version 1 dated 24 January 2025. The twelve-column clinical-trial table includes its printed example row, blank cells and investigational medicinal product references; it is also referenced by the trial progress report. Example dates and outcomes are not legal deadlines or general device vigilance rules. Later revisions and current applicability remain unverified.
MCA-F-501/14, Version 1 – 24 January 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.